This study is testing a drug called Olatorepatide to see how safe and effective it is for adults who are overweight or have obesity. Researchers will also learn how your body handles the drug. You might receive Olatorepatide or a placebo (an inactive substance) in this study. We are looking for about 120 participants between 18 and 65 years old who have a Body Mass Index (BMI) between 27.0 and 45.0 kg/m². You cannot have a history of Type 1 or Type 2 diabetes. The main goals are to track any side effects, measure how much Olatorepatide is in your blood, and see how well it works. The study status is currently unclear.

Study design

This interventional study plans to enroll 120 participants. It compares Olatorepatide to a placebo.

What's involved

You will need to attend all scheduled visits and follow the prescribed treatment regimen. The study will measure side effects and drug levels in your blood.

Compensation

Not stated in the trial record.

Follow-up

Side effects will be measured for up to approximately 30 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.